Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
12.29% $0.333
America/New_York / 23 apr 2024 @ 11:40
FUNDAMENTALS | |
---|---|
MarketCap: | 15.87 mill |
EPS: | -3.30 |
P/E: | -0.100 |
Earnings Date: | May 08, 2024 |
SharesOutstanding: | 47.67 mill |
Avg Daily Volume: | 7.19 mill |
RATING 2024-04-22 |
---|
B- |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Neutral | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.100 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -0.100 | industry: PE -4.88 |
DISCOUNTED CASH FLOW VALUE |
---|
$0.253 (-23.91%) $-0.0796 |
Date: 2024-04-23 |
Expected Trading Range (DAY) |
---|
$ 0.207 - 0.459 ( +/- 37.89%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Peizer Terren S | Buy | 90 548 129 | Common Stock Purchase Warrant |
2024-03-28 | Peizer Terren S | Buy | 86 574 073 | Common Stock Purchase Warrant |
2024-03-28 | Peizer Terren S | Sell | 86 574 073 | Common Stock Purchase Warrant |
2024-03-28 | Peizer Terren S | Sell | 36 666 666 | Common Stock Purchase Warrant |
2024-01-02 | Sherman Michael Edward | Buy | 332 333 | Option (right to buy) |
INSIDER POWER |
---|
45.91 |
Last 99 transactions |
Buy: 461 155 047 | Sell: 142 506 193 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.333 (12.29% ) |
Volume | 0.570 mill |
Avg. Vol. | 7.19 mill |
% of Avg. Vol | 7.92 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.